Literature DB >> 9742397

The WASp homologue Las17p functions with the WIP homologue End5p/verprolin and is essential for endocytosis in yeast.

S N Naqvi1, R Zahn, D A Mitchell, B J Stevenson, A L Munn.   

Abstract

Several end mutations that block the internalisation step of endocytosis in Saccharomyces cerevisiae also affect the cortical actin cytoskeleton [1]. END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3]. End5p interacts with actin [4], but its exact function is not yet known. To help elucidate End5p function, we sought other End5p-interacting proteins and identified the LAS17/BEE1 gene (encoding the yeast homologue of the human Wiskott-Aldrich Syndrome protein, WASp) as a high-copy-number suppressor of the temperature-sensitive growth and endocytic defects of end5-1 cells (carrying a frameshift mutation affecting the last 213 residues of End5p). LAS17 is unable to suppress a full deletion of END5 (end5 delta), however, suggesting that the defective End5-1p in end5-1 mutants may be stabilised by Las17p. The amino terminus of Las17p interacts with the carboxyl terminus of End5p in the yeast two-hybrid system and similar interactions have been shown between WASp and a mammalian End5p homologue, WASp-interacting protein (WIP) [5]. As las17 delta deletion mutants are blocked in endocytosis, we conclude that Las17p and End5p interact and are essential for endocytosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742397     DOI: 10.1016/s0960-9822(98)70396-3

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  54 in total

1.  Rho1p and Cdc42p act after Ypt7p to regulate vacuole docking.

Authors:  G Eitzen; N Thorngren; W Wickner
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

2.  The WASP/Las17p-interacting protein Bzz1p functions with Myo5p in an early stage of endocytosis.

Authors:  A Soulard; S Friant; C Fitterer; C Orange; G Kaneva; G Mirey; B Winsor
Journal:  Protoplasma       Date:  2005-10-20       Impact factor: 3.356

3.  Targeted disruption of an EH-domain protein endocytic complex, Pan1-End3.

Authors:  Karen Whitworth; Mary Katherine Bradford; Nicole Camara; Beverly Wendland
Journal:  Traffic       Date:  2013-10-31       Impact factor: 6.215

Review 4.  WASP and SCAR/WAVE proteins: the drivers of actin assembly.

Authors:  Alice Y Pollitt; Robert H Insall
Journal:  J Cell Sci       Date:  2009-08-01       Impact factor: 5.285

5.  The novel adaptor protein, Mti1p, and Vrp1p, a homolog of Wiskott-Aldrich syndrome protein-interacting protein (WIP), may antagonistically regulate type I myosins in Saccharomyces cerevisiae.

Authors:  Junko Mochida; Takaharu Yamamoto; Konomi Fujimura-Kamada; Kazuma Tanaka
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

6.  MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta.

Authors:  Jacquelyn A Woodings; Stewart J Sharp; Laura M Machesky
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

7.  Polarized hyphal growth in Candida albicans requires the Wiskott-Aldrich Syndrome protein homolog Wal1p.

Authors:  A Walther; J Wendland
Journal:  Eukaryot Cell       Date:  2004-04

8.  WASP family proteins: their evolution and its physiological implications.

Authors:  Douwe M Veltman; Robert H Insall
Journal:  Mol Biol Cell       Date:  2010-06-23       Impact factor: 4.138

9.  Enteropathogenic Escherichia coli and vaccinia virus do not require the family of WASP-interacting proteins for pathogen-induced actin assembly.

Authors:  John J Garber; Fuminao Takeshima; Inés M Antón; Michiko K Oyoshi; Anna Lyubimova; Archana Kapoor; Tomoyuki Shibata; Feng Chen; Frederick W Alt; Raif S Geha; John M Leong; Scott B Snapper
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

Review 10.  The WASP and WAVE family proteins.

Authors:  Shusaku Kurisu; Tadaomi Takenawa
Journal:  Genome Biol       Date:  2009-06-15       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.